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CLONING AND EXPRESSION OF THE HAEMAGGLUTININ­
NEURAMINIDASE (HN) GENE FROM NEWCASTLE DISEASE VIRUS 
(NDV) STRAIN AF2240 IN BACULOVIRUS (AcMNPV) 
By 
Alan Ong Han Kiat 
September 1999 
Chairman : Assoc. Prof. Kbatijah Mohd. Yusoff, Ph.D. 
Faculty : Science and Environmental Studies 
Newcastle disease virus strain AF2240 is a major threat to the poultry 
industry as it causes 100% mortality to susceptible flocks The haemagglutinin-
neuraminidase (HN) gene encodes for the fIN surface glycoprotein which is known 
for virus attachment and contains immunogenic properties Therefore, the HN gene 
was cloned into a Baculovirus Expression Vector system (BEVS) for the 
development of a subunit vaccine against NDV as well as to study its expression in 
isolation from the other NDV structural genes 
The approach taken involved the amplification (RT-PCR) of the I 8 kb HN 
gene, from NDV strain AF2240 genomic RNA and cloning it into a BEVS The 
xv 
recombinant baculovirus protein RecHNAF2240 expressed in Sj9 cells was shown to 
be positive for the haemagglutinin test (RA), neuraminidase test (NA), indirect 
immunofluorescence (IIF) as well as in SDS-PAGE Western blot analysis indicated 
the distinct - 63 kDa and - 75 kDa protein bands as HN specific which corresponded 
to the unglycosylated and glycosylated HN glycoproteins respectively This 
observation was confirmed by a time course study using pulsed-labeled esS] 
methionine of the HN glycoprotein in the recombinant virus infected cells with 
tunicamycin The recombinant protein was expressed not only on the surfaces of the 
infected cells and the viral coat protein but also appears to be biologically active and 
functional The physical nature of the viruses was also studied using electron 
microscopy (EM) and it indicated various physical differences 
Optimisation study on the recombinant protein RecHNAF2240 production 
showed that a late log phase infection of the recombinant virus (recHNAF2240) at an 
m 0 i of 1 was the most appropriate Based on HI, ELISA and western blot analysis 
the recombinant subunit vaccine was able to elicit a protective immune response 
The route of vaccination and a second dose were crucial to illicit an immune 
response from the chickens However, thiS protective feature of the recombinant 
subunit vaccine remains mconclusIve and more work should be carried out to bring 
about the fullest potential of this recombinant subunit vaccine 
XVI 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia untuk 
memenuhi keperluan ijazah Doktor Falsafah 
PENGKLONAN DAN PENGEKSPRESAN GEN HEAMGGLUTININ­
NEURAMINIDASE (HN) DARIPADA VIRUS PENY AKIT NEWCASTLE 
(NDV) STRAIN AF2240 KE DALAM BACULOVIRUS (AcMNPV) 
Oleh 
Alan Ong Han Kiat 
September 1999 
Pengerusi : Prof. Madya Khatijah Mohd. YusofT, Ph.D. 
Faculti : Sains and P�ngajian Alam Sekitar 
Virus penyakit Newcastle strain AF2240 merupakan penyakit virus utama 
dalam industri penternakan ayam kerana boleh menyebabkan 100% kematian ayam 
Gen HN yang mengkodkan glikoprotein permukaan HN memainkan peranan dalam 
perlekatan virus dan juga mempunyai nilai-nilai keimunan Oleh itu, gene HN telah 
diklonkan dalam Sistem pengekspresan vektor Baculovirus (BEVS) untuk 
penghasilan vaksin subunit terhadap NDV dan juga untuk mengkaji pengekspresan 
gen HN berasingan dengan gen-gen NDV yang lain 
Pendekatan yang digunakan adalah dengan melibatkan gen HN (1 8 kb) yang 
telah diamplifikasikan daripada jujukan RNA (RT-peR) dan diklonkan ke dalam 
XVll 
BEVS. Protein rekombinan baculovirus RecHNAF2240 yang diekpreskan dalam sel 
Sj9 menunjukkan keputusan yang positif untuk ujian hemaglutinin (HA), 
neuraminidase (NA), imunopendarfluoran (IIF) serta SDS-P AGE. Analisis "western 
blot" pula menunjukkan jalur protein - 63 kDa dan � 75 kDa sebagai specifik kepada 
protein HN yang bersamaan dengan glikoprotein HN yang masing-masing tidak 
mengalami glikosilasi dan yang mengalami glikosilasi. Keputusan tersebut juga 
telah didapati dengan menggunakan protein rekombinan yang dilabelkan dengan 
CSS] methionin dengan kehadiran antibiotic tunikamisin. Penemuan sedemikian 
membuktikan bahawa protein rekombinan diekspr�skan pada permukaan sel-sel yang 
dijangkiti virus rekombinan, pada permukaan protein perlindung virus dan adalah 
aktif secara biologikal serta berkebolehan berfungsi. Ciri-ciri fizikal virus yang 
berlainan juga telah dikaji dengan bantuan mikroskop electron (EM). 
Jangkitan virus rekombinan recHNAF2240 pada fasa log akhir pada m.o.i. 1 
merupakan nilai yang paling sesuai untuk penghasilan protein yang optimum. 
Penghasilan tindakan keimunan oleh vaksin subunit berdasarkan ujian ill, ELISA 
and analisis "Western blot" menunjukkan bahawa temp at vaksin disuntik and 
penggunaan dos kedua adalah perlu untuk menghasilkan tindakbalas imun daripada 
ayam-ayam yang dikaji. Namun demikian, ujian awal ini memberi maklumat yang 
penting tentang persoalan perlindungan ayam daripada jangkitan virus NDV dan 
ujian yang lebih menyeluruh adalah digalakan supaya dapat meningkatkan potensi 
vaksin rekombinan yang dihasilkan. 
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CHAPTER I 
INTRODUCTION 
The production of chicken in Malaysia ranks among the highest in the world 
in proportion to its population A 1992 survey reported in Asiaweek (20 April, 1994) 
on the various poultry producing countries in Asia, put Malaysia in 4th placing after 
China, India and Indonesia, the three highest populated countries in Asia 
Furthermore, the 1990 livestock statistics prepared by the Department of Veterinary 
Services (DVS) showed that the consumption and production of chicken was the 
highest among animal products (Figure 1a) The popularity of poultry products lies 
mainly on their nutritive values as both poultry meat and eggs production with 
regards to energy is simi lar to milk and is low in saturated fats Also, in Malaysia, 
the price of chicken among other common food sources appears to be the lowest 
(Figure 1b) 
The poultry industry in Malaysia was worth 1 5 billion ringgit in 1992 (more 
than 55% of the total value of livestocks) and in 1997, it rose to 4 5  bill ion ringgit 
With the intensification of the poultry industry, Malaysia is currently self-sufficient 
in poultry eggs and meat but at the same time, is exposed to the inevitable increase 10 
the prevalence of disease and loses 
a) 
b) 
Figure 1: 
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Comparison of Production, Consumption and Prices of Local Meat 
Sources. a) Production and Consumption of Animal Products in 1990 
(DVS Livestock Statistics, 1992) and b) Prices of Common Food 
Source in 1998 (The Star, 1998). 
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The greatest threat in the poultry industry, not only in Malaysia but also in 
Asia is Newcastle disease virus (NDV) that is responsible for 3 1 4  outbreak cases 
recorded in Malaysia between 1985 to 1987.  In 1 976, NDV caused the US a loss of 
around 215 mil l ion US dollars wherelse in Malaysia between 1 973 to 1 977, 9% of all 
mortality costing the country 3 .8 8  million ringgit annually was due to NDY. 
Vaccination appears to be the mam control of poultry viral disease in 
Malaysia and other developed as well as developing countries but NDV being 
endemic in this region, stil l  poses a threat despite routine vaccination programmes 
which cost 1 8  to 50 % of the DVS annual budget (1992). It cannot be denied that 
current vaccines (live attenuated or kil led) and local feed-delivered vaccines for 
vil lage chickens; a common source of NDV epidemics as well as the readily 
avai lable poultry health l ike vaccines and production technology from overseas have 
contributed towards improving the control of the disease. Nevertheless, these 
approaches alone may prove inadequate for Asia's rapid developing poultry industry 
to achieve long term stabil ity and self-sustainabil ity. 
Therefore, efforts are being made with the aide of the ever advancing 
recombinant DNA technology and molecular biology for the development of more 
suitable vaccines derived from local NDV strains which would further complement 
the needs of the country's poultry industry. The approach would also cater for a 
more effective improvement of viral disease control through research by uti l ising 
available local resources. The growing interest and appl ication of this technology 
has made possible the identification of specific sites on the surface of the virus which 
are crucial for inducing protective immune response. Taking advantage of this fact, 
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the production of vaccines from infectious agent which would not replicate as the 
pathogenic agent but able to induce immunity without causing any risk of increased 
or altered pathogenicity upon exposure to infection may bring about a more effective 
vaccIne 
In this study, a subunit vaccine was developed through the cloning of the HN 
gene from NDV strain AF224 0, isolated from the viral genomic nucleic acid, into a 
Baculovirus Expression Vector System (BEVS) The BEVS is capable of expressing 
high levels of recombinant viral protein complete with post-translational 
modification in insect cells It will also facil itate the study of the HN gene 
expression in isolation from the rest of the NDV structural genes Thus the 
objectives of this study are -
to isolate the HN gene using peR methods, 
2 to clone the HN gene into BEVS, 
3 to express the recombinant HN protein in SF9 insect cells, and 
4 to determine the functionality of the recombinant protein 
CHAPTER II 
LITERA TURE REVIEW 
Newcastle Disease Virus 
Taxonomic Classification 
Newcastle disease virus (NDV) is the aetiological agent of the Newcastle 
disease, one of the most serious infectious disease of poultry in many parts of the 
world including Malaysia The reclassification of virus taxa in 1 993 by the 
International Committee in the Taxonomy of Viruses (lCTV) grouped the NDV 
species into the Rubulavlrus genus of the Paramyxovmdae family in the order of 
Mononegavlrales (Murphy et al., 1 995, Pringle, 1 998) The other genera under the 
Paramyxovzrzdae family are the Morblltvlrus and the Paramyxovlrus where NDV 
was earlier classified together with mammalian parainfluenza virus type 1 -5 and 
mumps virus NDV is the prototype of the genus and is the only member of the 
avian paramyxovlrus - 1  (PMV-l) serotype Various other groups which are 
serological ly di stinguishable from NDV have been isolated from avian species and 
grouped into eight other serotypes called PMV -2 to PMV -9 (Alexander, 1 986) 
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History and Distribution of NDV 
The first outbreak ofNDV is known to occur in 1926 on the island of Java, 
Indonesia called Batavia showing high mortality (Brandly, 1964) At the same 
period, Doyle (1927) and Konno et al (1929) (cited in Brandly, 1964) reported a 
similar disease in Korea and in NewcastIe-on-Tyne, where the common name of the 
disease was coined. Three years later, NDV spread throughout the entire Southeast 
Asia (Lancaster, 1966) where it is now endemic (Aini, 1993), Australia (Johnstone, 
1931) and India (Brandly, 1964) Within 10 years, ND had been reported in Japan, 
Africa and subsequently in various other countries such as the Middle East as well as 
in Europe (Lancaster, 1966) Apparently, ND was only first reported in the US in 
1944 (Beach, 1944), Canada in 1948 and in South America in the 1950s (cited in 
Beard, 1984) 
Newcastle Diease Virus and the Malaysia Scenario 
In Peninsular Malaysia, the incidence of an ND outbreak was reported at Parit 
Buntar, Perak in 1934 causing high mortalities in susceptible chickens with necrotic 
lesions, respIratory signs, diarrhoea and eventually death (Whitworth, 1934, cited In 
Lim, 1994) Within a few years, it had spread to other states like Selangor, Melaka, 
Kedah and Johor (Wallace, 1939, cited in Lim, 1994) In contrast, the virulent ND 
is known to be associated with two sources namely wild bird species like psittacine 
birds and chickens The highly virulent virus termed as velogenic viscerotropic 
Newcastle disease (VVNO) virus is from the earlier source that killed domestic 
chickens within 2 to 4 days upon exposure (Lim, 1994) Pearson et al (1975) (cited 
